The drug registration procedure in Korea involves submitting an application to the Ministry of Food and Drug Safety (MFDS), including clinical trial data, safety information, and manufacturing details. MFDS reviews the application for efficacy, safety, and quality, followed by inspections. If approved, the drug can be marketed in Korea.